NSE filing, NSE: ICDSLTD. Summary written from the filing by ALFA Finder's alert engine.
ICDS Ltd: key numbers
- Share price
- ₹50.74
- Market cap
- ₹66.10 Cr
- Revenue (annual)
- ₹2.39 Cr
- Net profit (annual)
- ₹1.09 Cr
- P/E (TTM)
- 101.4×Sector 19.7×
- Promoter holding
- 51.39%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ICDS Ltd
All →ICDS Other Announcement
ICDS Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, pursuant to SEBI Regulation 31(1)(b). The report details the promoter and public holdings.
ICDS Annual General Meeting
ICDS Ltd conducted its 55th Annual General Meeting on September 24, 2026. Shareholders approved the financial statements, director re-appointment, and material related party transactions.
ICDS Price Movement Clarification
ICDS Limited clarified that it is unaware of any specific reasons for recent significant movements in its security price. The company confirmed all material information has been disclosed.
ICDS Annual General Meeting
ICDS Limited has scheduled its 55th Annual General Meeting for September 24, 2026. Key agenda items include the adoption of financial statements and director re-appointment.
- Value
- ₹0.22 Cr
ICDS Annual General Meeting
ICDS Ltd has scheduled its 55th Annual General Meeting for September 24, 2026. The company also announced a book closure period from September 18 to 24, 2026.
ICDS Q1 FY27 Results: Net Profit ₹0.9 Cr, Down 35.7% YoY
ICDS Ltd reported revenue from operations of ₹0.6 Cr (-25.0% YoY) and net profit of ₹0.9 Cr (-35.7% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.9 Cr · -35.7% YoY
Other other announcement announcements
All →Milky Mist Dairy Food Other Announcement
Milky Mist's board appointed B Chandra & Associates as Secretarial Auditors for FY 2026-27 to 2030-31. Shareholder approval is pending at the ensuing AGM.
- Execution
- FY 2026-27 to FY 2030-31 (five years)
Mahamaya Lifesciences Other Announcement
Mahamaya Lifesciences Ltd, an SME-platform listed company, confirms non-applicability of Corporate Governance under Regulation 27(2) for the quarter ended 30 September 2026. A Company Secretary certificate is enclosed.
Wipro Other Announcement
Wipro disclosed a designated person's 34,200-share ADR sale worth about ₹0.67 Crore on 28 October 2026. The sale followed RSU exercise, leaving 60,266 securities held.
- Value
- ₹0.67 Cr
OK Play India Other Announcement
OK Play India filed its quarterly shareholding pattern for the quarter ended September 2026. It shows category holdings only, with no transaction.
Spice Islands Industries Other Announcement
Spice Islands Industries filed a Reg 32 statement reporting no deviation in preferential issue fund utilization for Q3 FY27. The ₹8.70 Crore raise is fully deployed.
Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.